NovoCure Vs. Dyne Therapeutics Industry Stock Comparison

Sell

19

NVCR
NovoCure

Last Price:

15.64

Seasonality Move:

-4.91%

Sell

31

DYN
Dyne Therapeutics

Last Price:

33.84

Seasonality Move:

5.51%

Sell

19

NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

The current NovoCure [NVCR] share price is $15.61. The Score for NVCR is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
NVCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

31

Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics a Buy, Sell or Hold?

The current Dyne Therapeutics [DYN] share price is $33.83. The Score for DYN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
DYN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVCR Stock Price Chart

What is NovoCure's stock price today?

The NovoCure share price today is $15.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing slight selling pressure.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

The Dyne Therapeutics share price today is $33.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.

NVCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.61	Sell
Relative Strength Index (14 RSI):	36.46	Sell
Chaikin Money Flow:	-292186	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(16.37 - 18.61)	Sell
Bollinger Bands (100):	(16.83 - 21.25)	Sell

DYN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.64	Sell
Relative Strength Index (14 RSI):	40.26	Sell
Chaikin Money Flow:	-399891	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(31.67 - 41.65)	Sell
Bollinger Bands (100):	(30.76 - 42.62)	Sell

NVCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	16.64	Sell
20-day SMA:	17.18	Sell
50-day SMA:	18.34	Sell
200-day SMA:	16.64	Sell
8-day EMA:	16.41	Sell
20-day EMA:	17.11	Sell
50-day EMA:	17.81	Sell
200-day EMA:	19.96	Sell

DYN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	34.84	Sell
20-day SMA:	34.54	Sell
50-day SMA:	40.17	Sell
200-day SMA:	29.41	Buy
8-day EMA:	34.53	Sell
20-day EMA:	35.81	Sell
50-day EMA:	37.51	Sell
200-day EMA:	30.51	Buy

NovoCure Earnings Growth & NVCR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and a decrease next year of $0.12 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.82 per share, and a decrease next year of $0.01 per share.

NovoCure Technical Analysis

	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20	Sep 23	Sep 24	Sep 25	Sep 26	Sep 27
	Sep
	16	17	18	19	20	23	24	25	26	27
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20	Sep 23	Sep 24	Sep 25	Sep 26	Sep 27
	Sep
	16	17	18	19	20	23	24	25	26	27
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):